Search results for: 'diseas virtualization market size'

After experiencing a significant post-Covid slump, the webinars and virtual events market returned to moderate growth in 2024. Growing at 4.8 percent over the previous year, revenue in 2024 is estimated to reach $1.45 billion. As in-person event attendance surged to its highest level in more than four years, event vendors have realigned their sol...

For more than two decades, VMware has dominated the enterprise virtualization market. The company’s hypervisor is a leader for virtualizing enterprise, on-premises workloads. As businesses have migrated to the cloud, VMware has adapted to maintain its leadership by partnering with cloud hyperscalers to offer virtualized cloud solutions that offer...

This report is a thorough examination of the current and future face of therapy for neurodegenerative diseases, such as Alzheimer's and Parkinson's. It articulates important growth drivers (e.g., precision medicine, AI paradigm for diagnostics, and the transformational megatrends of aging populations) and barriers they will face (e.g., the nature o...

Virtual reality (VR) is an interactive three-dimensional (3D) environment that is computer generated. Immersion into VR is an individual’s perception of having a physical presence in the non-physical world or the virtual world. Technology advancement in in VR in the recent years has led to significant improvements in quality, reductions in overall ...

22 Aug 2024  |  Global  |  Technology Research

Pipeline Assessment for Cardiovascular Diseases

Advanced Drug Modalities Fuel Cardiovascular Therapeutics Future Growth Potential

Infographics

×

Globally, CVD is the leading cause of death, with resurgence in higher-income countries and higher prevalence in low- and middle-income countries. While there have been many advancements made to this indication using wearables and advanced diagnostics and devices, growth in therapeutics has been veiled. Traditional pharmacotherapy faces the drawbac...

The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...

The fifth generation (5G) of wireless technology has arrived and is being rolled out globally. 5G is possible because of the contributions of previous generations of wireless communications and several disruptive technologies, each of which must be understood at least at a high level to paint a full picture of the industry. This study centers on op...

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...

Mitochondria are vital structures in the human body, and they play an active role in several processes. They are widely recognized as the powerhouses of the cell because of their essential function in energy production. In addition, mitochondria have a significant impact on several functions of the human body; as a result, any dysfunction in mitoch...